Back to trial details

Intake questionnaire

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Applying to University of California Irvine Center for Clinical Research · Irvine, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 22 and 60 years old?
2. Have you been diagnosed with Relapsing Remitting Multiple Sclerosis?
3. Are you able to travel to Irvine for study visits?